Table 2.

Patient CD4 T-cell counts and CSF analysis by disease groupa

Disease groupMean CD4 T-cell count (cells/mm3)Mean CSF WBC count (cells/μl)Mean CSF protein levelb (mg/dl)Mean CSF glucose levelc (mg/dl)
A159 (1–484)1 (0–2)53 (30–98)73 (45–160)
B137 (0–1,245)44d (0–614)61 (2–202)47 (4–71)
C71 (3–455)30 (0–320)90 (31–364)46 (34–63)
D66 (19–155)13 (0–35)57 (34–105)47 (37–58)
E53 (3–355)40e (1–320)106 (41–364)45 (34–63)
  • a Values in parentheses are ranges. Group A, no neurologic disease; group B, non-HCMV neurologic disease; group C, all CSF samples from patients with HCMV CNS in the initial differential diagnosis; group D, nonneural HCMV disease; group E, confirmed HCMV CNS disease.

  • b CSF protein normal range, 15 to 45 mg/dl.

  • c CSF glucose normal range, 40 to 70 mg/dl.

  • d P = 0.0348 for group B CSF WBC count compared to group A CSF WBC count (Wilcoxon two-sample test).

  • e P = 0.012 for group E CSF WBC count compared to group A CSF WBC count (Wilcoxon two-sample test).